Transmedics Group Inc (TMDX) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Sep 14, 2026.
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
- Filings shown
- 8
- Open-market buys
- 1
- Open-market sells
- 1
- Buys, 10b5-1 box not checked
- 1 of 1
Counts cover the 8 most recent Form 4 filings Tradune holds for TMDX (filed May 22 – Sep 14, 2026); the score below covers only the trailing 90 days (1 buy, 0 sells). No completed check of TMDX's Form 4 list on SEC EDGAR is on record yet; the latest TMDX filing Tradune holds was filed Sep 14, 2026. This is not guaranteed to be the complete record — see TMDX's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 2 filings Tradune holds for TMDX filed Aug 17 – Sep 14, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| David WeillDirector | 1 | 0 | 1,336 | — | +$109,058 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at TMDX
Insiders reported 1 open-market purchase of TMDX between May 22, 2026 and Sep 14, 2026, across 1 distinct buyer. The most recent purchase was reported by David Weill (Director) on Sep 11, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 1,336 | $81.63 | 16,392 | +8.9% | Sep 11, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Gift | 18,000 | — | 0 (indirect) | −100% | Aug 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 11,727 | — | 41,558 | +39% | Jul 10, 2026 |
| Grant / award Stock Option (Right to Buy) | 17,784 | — | — | — | Jul 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 17,246 | — | 31,935 | +117% | Jul 10, 2026 |
| Grant / award Stock Option (Right to Buy) | 26,153 | — | — | — | Jul 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 49,669 | — | 171,093 | +41% | Jul 10, 2026 |
| Grant / award Stock Option (Right to Buy) | 112,984 | — | — | — | Jul 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 19,285 | $2.21 | 26,266 | +276% | Jun 15, 2026 |
| Open-market sale 10b5-1 box not checked | 9,624 | $75.06 | 16,642 | −37% | Jun 15, 2026 |
| Option exercise Stock Option (Right to Buy) | 19,285 | — | — | — | Jun 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 2,922 | — | 5,788 | +102% | May 20, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 2,922 | — | 15,056 | +24% | May 20, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to TMDX's (Sep 14, 2026).
Frequently asked about TMDX insider activity
How many insiders bought TMDX stock in these Form 4 filings?
1 distinct insider at Transmedics Group Inc reported 1 open-market purchase (Form 4 code P) of TMDX shares between May 22, 2026 and Sep 14, 2026, the most recent filed by David Weill (Director) on Sep 11, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for TMDX?
The most recent Form 4 on this page was filed by David Weill (Director) on Sep 14, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market TMDX insider sale shown?
The largest open-market sale among the filings shown was 9,624 TMDX shares at $75.06 (about $722,377) by Thomas J. Gunderson (Director) on Jun 15, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent TMDX insider purchases have the Form 4 10b5-1 box checked?
No. The one TMDX open-market purchase shown was reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: David Weill (Director) on Sep 11, 2026, 1,336 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for TMDX — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
Track TMDX insider filings free →This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.